TrialClinical ophthalmology (Auckland, N.Z.)2023

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis.

María Cecilia Marini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.